D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACGN
3101
DELISTED
Aceragen Inc
ACGN
| $424K | ﹤0.01% |
9,346
+3,587
| +62% | +$170K |
|
3102
Kforce
KFRC
$983M
| $423K | ﹤0.01% |
+12,041
| New | +$433K |
|
3103
Omega Healthcare
OHI
$15.4B
| $423K | ﹤0.01% |
11,500
-13,471
| -54% | -$491K |
|
|
TRK
3104
DELISTED
Speedway Motorsports, Inc.
TRK
| $422K | ﹤0.01% |
22,763
+884
| +4% | +$15.3K |
|
3105
Ameren
AEE
$31.5B
| $421K | ﹤0.01% |
5,600
+369
| +7% | +$27.2K |
|
3106
Resources Connection
RGP
$129M
| $421K | ﹤0.01% |
26,308
+4,656
| +22% | +$74.2K |
|
3107
SouthState Bank Corp
SSB
$10.3B
| $421K | ﹤0.01% |
5,710
+1,256
| +28% | +$90.3K |
|
|
CHK
3108
DELISTED
Chesapeake Energy Corporation
CHK
| $419K | ﹤0.01% |
1,073
+564
| +111% | +$282K |
|
3109
PUT
Kinder Morgan
KMI
$73.1B
| $418K | ﹤0.01% |
20,000
| – | – |
|
3110
Interactive Brokers
IBKR
$40.9B
| $416K | ﹤0.01% |
+30,356
| New | +$412K |
|
3111
PUT
Boston Beer
SAM
$1.88B
| $416K | ﹤0.01% |
+1,100
| New | +$348K |
|
3112
PUT
FMC
FMC
$1.42B
| $415K | ﹤0.01% |
5,000
| – | – |
|
3113
PUT
Matador Resources
MTDR
$6.31B
| $415K | ﹤0.01% |
20,900
-8,200
| -28% | -$156K |
|
3114
German American Bancorp
GABC
$1.82B
| $414K | ﹤0.01% |
13,731
+5,241
| +62% | +$154K |
|
|
LKFT
3115
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.82B
| $414K | ﹤0.01% |
3,208
-19,691
| -86% | -$2.34M |
|
|
HIMX
3116
Himax Technologies
HIMX
$2.2B
| $414K | ﹤0.01% |
+118,961
| New | +$393K |
|
|
SFE
3117
DELISTED
Safeguard Scientifics, Inc.
SFE
| $414K | ﹤0.01% |
34,323
-8,576
| -20% | -$100K |
|
3118
Community Trust Bancorp
CTBI
$1.38B
| $413K | ﹤0.01% |
9,772
+1,646
| +20% | +$68.3K |
|
3119
Quad
QUAD
$430M
| $413K | ﹤0.01% |
52,248
-40,172
| -43% | -$420K |
|
3120
Ryman Hospitality Properties
RHP
$8.4B
| $412K | ﹤0.01% |
5,083
-800
| -14% | -$65.5K |
|
|
CRZO
3121
CALL
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $412K | ﹤0.01% |
41,100
+1,800
| +5% | +$20.7K |
|
3122
Lexicon Pharmaceuticals
LXRX
$1.02B
| $411K | ﹤0.01% |
65,437
-170,684
| -72% | -$1.02M |
|
3123
Rollins
ROL
$18.6B
| $411K | ﹤0.01% |
+17,177
| New | +$443K |
|
|
CHK
3124
CALL
DELISTED
Chesapeake Energy Corporation
CHK
| $410K | ﹤0.01% |
1,050
| – | – |
|
|
PVLA
3125
Palvella Therapeutics
PVLA
$1.98B
| $407K | ﹤0.01% |
1,082
+165
| +18% | +$49.2K |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.